HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Angio-immunoblastic lymphadenopathy].

Abstract
Angioimmunoblastic lymphadenopathy is a rare lymphoproliferative disease with a poor prognosis. We saw a 24-year-old female patient with a fulminant evolution of an angioimmunoblastic lymphadenopathy, possibly a recurrence after a 10 years remission.
AuthorsN J Struyf, J A Verhelst, C G Convens, W J Beelaerts, R J Mathijs, C Mahler
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 137 Issue 30 Pg. 1516-8 (Jul 24 1993) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleAngio-immunoblastische lymfadenopathie.
PMID8366940 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Female
  • Humans
  • Immunoblastic Lymphadenopathy (diagnosis, drug therapy)
  • Male
  • Prednisone (administration & dosage)
  • Prognosis
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: